Jing Wu, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jing Wu, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:47 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07374692 · Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) TumorsNational Cancer Institute (NCI) · completed · Recurrent CNS Tumors, Brain Cancer, Gliomas · principal investigator
- Ph2NCT03952598 · Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR SpectroscopyNational Cancer Institute (NCI) · completed · Glioma, Gliomas, High Grade Glioma · principal investigator
- Ph2NCT03718767 · Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator PhenotypeNational Cancer Institute (NCI) · active not recruiting · Glioma, Glioblastoma, High Grade Glioma · principal investigator
- Ph1/Ph2NCT02942264 · Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and GlioblastomaNational Cancer Institute (NCI) · terminated · Brain Tumor, Astrocytoma, Astroglioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.